Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DSC-COVID-19: An Open-label Study on the Safety and Efficacy of Decidual Stromal Cells in Respiratory Failure Induced by COVID-19

NCT04451291 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04451291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04451291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DSC-COVID-19: An Open-label Study on the Safety and Efficacy of Decidual Stromal Cells in Respiratory Failure Induced by COVID-19
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
September 25, 2020
Completion date
November 7, 2023
Enrollment
19 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, covid-19